ADMET & DMPK X(Y) (20xx) pp-pp; doi: 10


doi: 10.5599/admet.1.4.20 82 

ADMET & DMPK 1(4) (2013) 82-82; doi: 10.5599/admet.1.4.20 

 
Open Access : ISSN : 1848-7718  

http://www.pub.iapchem.org/ojs/index.php/admet/index   

 

Editorial Board Member: brief biography 

Kin Tam 

 

 

Dr. Kin Tam holds a DPhil in Physical Chemistry from the University of Oxford, UK. He is currently 

Associate Professor in Biomedical Sciences of the Faculty of Health Sciences, University of Macau, China. 

Before moving back to China in 2013, he worked for AstraZeneca, Alderley Park, UK, for 12 years, 

progressing from Senior Scientist, to Associate Principal Scientist, and working as a DMPK Design Leader 

from 2011. He contributed to a number of drug discovery projects in the areas of oncology and led the 

development of high-throughput physicochemical assays. Prior to joining AstraZeneca, he developed new 

instruments with Sirius Analytical Instruments, UK, for 5 years and commercialised UV-based devices for 

pKa determination. His current research interests include permeability and physiochemical studies of drug 

molecules, drug metabolism and pharmacokinetics as well as drug development. He has authored or 

co-authored over 70 articles in peer review journals. Dr. Tam is a Fellow of the Royal Society of Chemistry. 

He is currently the Editor-in-chief for ADMET & DMPK. 

 

 

 

©2013 by the authors; licensee IAPC, Zagreb, Croatia. This article is an open-access article distributed under the terms and 
conditions of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/)  

 

http://www.pub.iapchem.org/ojs/index.php/admet/index
http://creativecommons.org/licenses/by/3.0/